Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
CR-4056 by Rottapharm Biotech for Osteoarthritis Pain: Likelihood of Approval
CR-4056 is under clinical development by Rottapharm Biotech and currently in Phase II for Osteoarthritis Pain. According to GlobalData, Phase...